Almac Diagnostics Limited
7Patents
7Active
7Granted
45Portfolio score
Filing activity: Sep 15, 2011 → Aug 13, 2015
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10196691B2 | Colon cancer gene expression signatures and methods of use | Chemistry; Metallurgy | 60 | Active |
| US10260097B2 | Method of using a gene expression profile to determine cancer responsiveness to an anti-angiogenic agent | Physics | 7 | Active |
| US10280468B2 | Molecular diagnostic test for predicting response to anti-angiogenic drugs and prognosis of cancer | Chemistry; Metallurgy | 4 | Active |
| US10214777B2 | Molecular diagnostic test for cancer | Chemistry; Metallurgy | 1 | Active |
| US9670547B2 | Molecular diagnostic test for cancer | Chemistry; Metallurgy | 0 | Active |
| US9677140B2 | Molecular diagnostic test for cancer | Chemistry; Metallurgy | 0 | Active |
| US10196697B2 | Prostate cancer classification | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.